Increased Risk for Metabolic Syndrome in Persons Seeking Care for Mental Disorders

References

• Meigs JB: Epidemiology of the metabolic syndrome, 2002. Am J Manag Care 2002; 8:S283–S292
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287:356–359
   Google Scholar
• National Institutes of Health: Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda, MD: National Institutes of Health, 2001
   Google Scholar
• Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J: Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003; 64:575–579
   Google Scholar
• Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP: Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004; 66:316–322
   Google Scholar
• Raikkonen K, Matthews KA, Kuller LH: The relationship between psychological risk attributes and the metabolic syndrome in healthy women: Antecedent or consequence? Metabolism 2002; 51:1573–1577
   Google Scholar
• Kato MM, Currier MB, Gomez CM, Hall L, Gonzalez-Blanco M: Prevalence of metabolic syndrome in Hispanic and Non-Hispanic patients with schizophrenia. Prim Care Companion J Clin Psychiatry 2004; 6:74–77
   Google Scholar
• Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH: Smoking and mental illness: A populationbased prevalence study. JAMA 2000; 284:2606–2610
   Google Scholar
• Schwartz TL, Nihalani N, Jindal S, Virk S, Jones N: Psychiatric medication-induced obesity: a review. Obes Rev 2004; 5:115–21
   Google Scholar
• Keck PE, McElroy SL: Bipolar disorder, obesity, and pharmacotherapy- associated weight gain. J Clin Psychiatry 2003; 64:1426–1435
   PubMed Web of Science ®Google Scholar
• Gratzer D, Levitan RD, Sheldon T, Toneatto T, Rector NA, Goering P: Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: A community survey of Ontario. J Affect Disord 2004; 79:209–215
   Google Scholar
• McCreadie RG: Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study. Br J Psychiatry 2003; 183:534–539
   Google Scholar
• Goodwin RD: Association between physical activity and mental disorders among adults in the United States. Prev Med 2003; 36:698–703
   Google Scholar
• McCreadie R, Macdonald E, Blacklock C, et al.: Dietary intake of schizophrenic patients in Nithsdale, Scotland: Case-control study. BMJ 1998; 317:784–785
   Google Scholar
• Toalson P, Saeeduddin A, Hardy T, Kabinoff G: The metabolic syndrome in patients with severe mental illnesses. Prim Care Companion J Clin Psychiatry 2004; 6:152–158
   Google Scholar
• Vanina Y, Podolskaya A, Sedky K, et al.: Body weight changes associated with psychopharmacology. Psychiatr Serv 2002; 53:842–847
   Google Scholar
• Kabinoff GS, Toalson PA, Healey KM, McGuire HC, Hay DP: Metabolic issues with atypical antipsychotics in primary care: Dispelling the myths. Prim Care Companion J Clin Psychiatry 2003; 5:6–14
   Google Scholar
• Yoon YS, Oh SW, Baik HW, Park HS, Kim WY: Alcohol consumption and the metabolic syndrome in Korean adults: The 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr 2004; 80:217–224
   Google Scholar
• Ryan MC, Thakore JH: Physical consequences of schizophrenia and its treatment: The metabolic syndrome. Life Sci 2002; 71:239–257
   Google Scholar
• American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27:596–601
   Google Scholar
• Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW: Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2003; 158:1139–1147
   Google Scholar
• Marchesini G, Forlani G, Cerrelli F, et al.: WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med 2004; 21: 383–387
   Google Scholar
• Marchesini G, Melchionda N, Apolone G, et al.: The metabolic syndrome in treatment-seeking obese persons. Metabolism 2004; 53:435–440
   Google Scholar
• American Association of Clinical Endocrinologists: New ICD-9- CM Code for Dysmetabolic Syndrome X. Jacksonville, FL, 2004
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC, 1994
   Google Scholar
• Lurie N, Popkin M, Dysken M, Moscovice I, Finch M: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry 1992; 43:69–71
   Google Scholar
• Palaniappan L, Carnethon MR, Wang Y, et al.: Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27:788–793
   Google Scholar
• Elmslie JL, Silverstone JT, Mann JI, Williams SM, Romans SE: Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000; 61:179–184
   Google Scholar
• McIntyre RS, Trakas K, Lin D, et al.: Risk of weight gain associated with antipsychotic treatment: Results from the Canadian National Outcomes Measurement Study in Schizophrenia. Can J Psychiatry 2003; 48:689–694
   Google Scholar
• Faulkner G, Soundy AA, Lloyd K: Schizophrenia and weight management: A systematic review of interventions to control weight. Acta Psychiatr Scand 2003; 108:324–332
   PubMed Web of Science ®Google Scholar
• Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M: Managing atypical antipsychotic-associated weight gain: 12- month data on a multimodal weight control program. J Clin Psychiatry 2004; 65:471–477
   Google Scholar
• Park HS, Oh SW, Cho SI, Choi WH, Kim YS: The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004; 33:328–336
   Google Scholar
• Himelhoch S, Daumit G: To whom do psychiatrists offer smokingcessation counseling? Am J Psychiatry 2003; 160:2228–2230
   Google Scholar
• Evins AE, Cather C, Rigotti NA, et al.: Two-year follow-up of a smoking cessation trial in patients with schizophrenia: Increased rates of smoking cessation and reduction. J Clin Psychiatry 2004; 65:307–311; quiz 452–453
   Google Scholar